Your browser doesn't support javascript.
loading
Phylogenetic landscape of Monkeypox Virus (MPV) during the early outbreak in New York City, 2022.
Patiño, Luz H; Guerra, Susana; Muñoz, Marina; Luna, Nicolas; Farrugia, Keith; van de Guchte, Adriana; Khalil, Zain; Gonzalez-Reiche, Ana Silvia; Hernandez, Matthew M; Banu, Radhika; Shrestha, Paras; Liggayu, Bernadette; Firpo Betancourt, Adolfo; Reich, David; Cordon-Cardo, Carlos; Albrecht, Randy; Pearl, Rebecca; Simon, Viviana; Rooker, Aria; Sordillo, Emilia Mia; van Bakel, Harm; García-Sastre, Adolfo; Bogunovic, Dusan; Palacios, Gustavo; Paniz Mondolfi, Alberto; Ramírez, Juan David.
Affiliation
  • Patiño LH; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Guerra S; Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain.
  • Muñoz M; Facultad de Ciencias Naturales, Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Universidad del Rosario, Bogotá, Colombia.
  • Luna N; Facultad de Ciencias Naturales, Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Universidad del Rosario, Bogotá, Colombia.
  • Farrugia K; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • van de Guchte A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Khalil Z; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gonzalez-Reiche AS; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Hernandez MM; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Banu R; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Shrestha P; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Liggayu B; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Firpo Betancourt A; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Reich D; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Cordon-Cardo C; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Albrecht R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Pearl R; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Simon V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Rooker A; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sordillo EM; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • van Bakel H; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • García-Sastre A; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bogunovic D; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Palacios G; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Paniz Mondolfi A; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ramírez JD; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Emerg Microbes Infect ; 12(1): e2192830, 2023 Dec.
Article in En | MEDLINE | ID: mdl-36927408
ABSTRACT
Monkeypox (MPOX) is a zoonotic disease endemic to regions of Central/Western Africa. The geographic endemicity of MPV has expanded, broadening the human-monkeypox virus interface and its potential for spillover. Since May 2022, a large multi-country MPV outbreak with no proven links to endemic countries has originated in Europe and has rapidly expanded around the globe, setting off genomic surveillance efforts. Here, we conducted a genomic analysis of 23 MPV-infected patients from New York City during the early outbreak, assessing the phylogenetic relationship of these strains against publicly available MPV genomes. Additionally, we compared the genomic sequences of clinical isolates versus culture-passaged samples from a subset of samples. Phylogenetic analysis revealed that MPV genomes included in this study cluster within the B.1 lineage (Clade IIb), with some of the samples displaying further differentiation into five different sub-lineages of B.1. Mutational analysis revealed 55 non-synonymous polymorphisms throughout the genome, with some of these mutations located in critical regions required for viral multiplication, structural and assembly functions, as well as the target region for antiviral treatment. In addition, we identified a large majority of polymorphisms associated with GA > AA and TC > TT nucleotide replacements, suggesting the action of human APOBEC3 enzyme. A comparison between clinical isolates and cell culture-passaged samples failed to reveal any difference. Our results provide a first glance at the mutational landscape of early MPV-2022 (B.1) circulating strains in NYC.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Monkeypox virus / Mpox (monkeypox) Limits: Humans Country/Region as subject: America do norte Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Monkeypox virus / Mpox (monkeypox) Limits: Humans Country/Region as subject: America do norte Language: En Year: 2023 Type: Article